drugdeliverybusiness15h
Senseonics submits year-long CGM for CE mark
Senseonics announced today that it filed for CE mark for its Eversense 365 continuous glucose monitor (CGM) system.
Senseonics files for Eversense 365 CE Mark registration
Senseonics has filed to obtain CE Mark registration for its one-year continuous glucose monitoring (CGM) system, Eversense ...
Senseonics Completes CE Mark Submission for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor
Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...
Insulin Pump Market to Reach US$ 25.40 Billion By 2033 | Astute Analytica
Insulin pump market growth is propelled by advancements in technology, rising global diabetes prevalence, and increased demand for precision diabetes management.New Delhi, Feb. 06, 2025 (GLOBE ...
الشرق الأوسط2d
Iran Calls for OPEC to Unite against Potential US Oil Sanctions
Iran's President Masoud Pezeshkian urged OPEC members to unite against possible US sanctions, after US President Donald Trump ...
Schools aren’t as plugged in as they should be to kids’ diabetes tech, parents say
Families want nurse or staff to monitor apps remotely in case of urgent alarms; schools cite shrinking budgets and internet ...
Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade
Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period ...
drugdeliverybusiness6d
Trinity Biotech expects to submit ‘disruptive’ next-gen CGM to FDA in 2026
(Nasdaq:TRIB) announced new pre-pivotal clinical data supporting its next-generation continuous glucose monitor (CGM) system.